RecruitingNot ApplicableNCT04297085

Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence

Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence. BREIZH-Cohorte


Sponsor

University Hospital, Brest

Enrollment

3,400 participants

Start Date

May 28, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The main objective of the BREIZH-Cohorte study is to determine the incidence of recurrent short, medium and long-term thromboembolic venous disease as well as risk factors for recurrence in two specific populations: patients under 50 years of age, men and women (5 year recurrence), as well as cancer patients (all ages) (1 year recurrence).


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is looking at why blood clots (called venous thromboembolism, or VTE) come back in some people and not others. When a blood clot forms in a vein — usually in the leg (deep vein thrombosis) or the lungs (pulmonary embolism) — there is always a risk it could happen again. Researchers want to understand what factors — such as age, lifestyle, medical history, or blood tests — predict who is most likely to have a repeat clot. This is an observational study, meaning researchers will follow participants over time and collect information, but will not change or prescribe any treatments. Participants will be asked questions about their health and may have blood samples taken. The goal is to build a clearer picture of recurrence risk so that doctors can better tailor preventive treatment for each patient. You may be eligible if you: - Are 18 years of age or older (or a minor with parental consent) - Are 50 years old or younger, OR have an active cancer diagnosis at any age - Have been diagnosed with a venous thromboembolic disease (blood clot) - Are affiliated with social security - Are willing to participate You may NOT be eligible if you: - Have difficulty communicating or understanding (comprehension disorder) - Refuse to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBiologic sample

Biological samples will be taken from the subjects included


Locations(4)

CHRU Brest

Brest, France

HIA Clermont Tonnerre Brest

Brest, France

CH Morlaix

Morlaix, France

CH de Cornouaille

Quimper, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04297085